Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Machine learning can identify newly diagnosed patients with CLL at high risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Ibrutinib and Venetoclax for First-Line Treatment of CLL

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The treatment of chronic lymphocytic leukemia (CLL) is in rapid transition, and during recent decades both combination chemotherapy and immunotherapy have been introduced. To evaluate the effects of this development, we identified all CLL patients registered in the nation-wide Danish Cancer Register between 1978 and 2013. We identified 10 455 CLL patients and 508 995 CLL-free control persons from the general population. Compared with the latter, the relative mortality rate between CLL patients and their controls decreased from 3.4 (95% CI 3.2-3.6) to 1.9 (95% CI 1.7-2.1) for patients diagnosed in 1978-1984 and 2006-2013, respectively. The improved survival corresponded to a decreasing risk of death from malignant hematological diseases, whereas the risk of death from infections was stable during the study period. These population-based data substantiate the improved survival for patients treated with chemo-immunotherapy demonstrated in clinical studies.

Original languageEnglish
JournalBlood Cancer Journal
Volume6
Issue number11
Pages (from-to)e499
ISSN2044-5385
DOIs
Publication statusPublished - 11 Nov 2016

    Research areas

  • Journal Article

ID: 49896691